Host response to pulmonary fungal infections: A highlight on cell-driven immunity to Cryptococcus species and Aspergillus fumigatus

Orchi Dutta^{1

2}, Jorge A Masso-Silva^{1

2}, Keyi Wang^{1

2}, Amariliz Rivera^{1

3}

Affiliations

¹ Center for Immunity and Inflammation New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, NJ 07103, USA.
² Graduate School of Biomedical Sciences, RBHS, Newark, NJ 07103, USA.
³ Department of Pediatrics, New Jersey Medical School, RBHS, Newark, NJ 07103, USA.

Orchi Dutta et al. Curr Pharmacol Rep. 2017 Dec.

. 2017 Dec;3(6):335-345.

doi: 10.1007/s40495-017-0111-4. Epub 2017 Oct 14.

Orchi Dutta^{1

2}, Jorge A Masso-Silva^{1

2}, Keyi Wang^{1

2}, Amariliz Rivera^{1

3}

¹ Center for Immunity and Inflammation New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, NJ 07103, USA.
² Graduate School of Biomedical Sciences, RBHS, Newark, NJ 07103, USA.
³ Department of Pediatrics, New Jersey Medical School, RBHS, Newark, NJ 07103, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest All authors declare that they have no conflicts of interest to disclose.

1. Brown GD, Denning DW, Levitz SM. Tackling human fungal infections. Science. 2012;336(6082):647. - PubMed
1. Mortensen KL, et al. Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother. 2010;54(11):4545–9. - PMC - PubMed
1. Bader O, et al. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Antimicrob Agents Chemother. 2013;57(8):3513–7. - PMC - PubMed
1. Orni-Wasserlauf R, et al. Fluconazole-Resistant Cryptococcus neoformans Isolated from an Immunocompetent Patient without Prior Exposure to Fluconazole. Clinical Infectious Diseases. 1999;29(6):1592–1593. - PubMed
1. Ashu EE, et al. Global Population Genetic Analysis of Aspergillus fumigatus. mSphere. 2017;2(1) - PMC - PubMed